Back

Bare metal stents vs drug-eluting stents.

1 September 2019 (17:26 - 17:50)
Organised by:
Congress Presentation Part of: The Lancet-ESC symposium on ischemic heart disease Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)

2 More presentations in this session

Presentation thumbnail
Primary prevention of ischemic heart disease.
Professor R. Gupta (Jaipur, IN)
Slides Video
Presentation thumbnail
Secondary prevention of ischemic heart disease.
Professor K. Ray (London, GB)
Slides Video

Access the full session

Session thumbnail
The Lancet-ESC symposium on ischemic heart disease

The Event

Event poster

ESC Congress 2019

1 September 2019 17:26 CET
You may be interested in
thumbnail
Congress Presentation
Titanium-nitride-oxide-coated vs drug-eluting stents in acute coronary syndromes during five-year follow-up: an individual patient data meta-analysis
31 August 2024
thumbnail
Congress Presentation
Incidence and outcomes of bailout stenting following use of drug coated balloon
31 August 2019
thumbnail
Congress Presentation
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study
1 September 2020
thumbnail
Congress Presentation
A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources